Skip to main content

and
  1. Article

    Open Access

    The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria

    Immunization with Plasmodium sporozoites, either attenuated or administered under the cover of an antimalarial drug, can induce strong protection against malaria in pre-clinical murine models, as well as in human...

    Diana Moita, Catarina Rôla, Helena Nunes-Cabaço, Gonçalo Nogueira in npj Vaccines (2023)

  2. Article

    Open Access

    A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria

    Two malaria parasite species, Plasmodium falciparum (Pf) and P. vivax (Pv) are responsible for most of the disease burden caused by malaria. Vaccine development against this disease has focused mainly on Pf. Whol...

    Diana Moita, Teresa G. Maia, Miguel Duarte, Carolina M. Andrade in npj Vaccines (2022)

  3. Article

    Open Access

    Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver

    Whole-sporozoite (WSp) malaria vaccines induce protective immune responses in animal malaria models and in humans. A recent clinical trial with a WSp vaccine comprising genetically attenuated parasites (GAP) w...

    Blandine Franke-Fayard, Catherin Marin-Mogollon, Fiona J. A. Geurten in npj Vaccines (2022)

  4. Article

    Open Access

    Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins

    The transmissible forms of Plasmodium parasites result from a process of sporogony that takes place inside their obligatory mosquito vector and culminates in the formation of mammalian-infective parasite forms. I...

    Raquel Azevedo, António M. Mendes, Miguel Prudêncio in Parasites & Vectors (2019)

  5. Article

    Open Access

    Pre-clinical evaluation of a P. berghei-based whole-sporozoite malaria vaccine candidate

    Whole-sporozoite vaccination/immunization induces high levels of protective immunity in both rodent models of malaria and in humans. Recently, we generated a transgenic line of the rodent malaria parasite P. berg...

    António M. Mendes, Isaie J. Reuling, Carolina M. Andrade, Thomas D. Otto in npj Vaccines (2018)

  6. Article

    Open Access

    A Plasmodium berghei sporozoite-based vaccination platform against human malaria

    There is a pressing need for safe and highly effective Plasmodium falciparum (Pf) malaria vaccines. The circumsporozoite protein (CS), expressed on sporozoites and during early hepatic stages, is a leading target...

    António M. Mendes, Marta Machado, Nataniel Gonçalves-Rosa, Isaie J. Reuling in npj Vaccines (2018)

  7. No Access

    Chapter

    Whole-Sporozoite Malaria Vaccines

    Whole-sporozoite administration is the sole immunization strategy that has been shown to elicit sterile immunity against malaria. Sporozoite-based immunization aims at eliciting potent pre-erythrocytic immune ...

    António M. Mendes, Anja Scholzen, Ann-Kristin Mueller, Shahid M. Khan in Malaria (2017)